YuliyaAfinogenovaMDMHS
Internal Medicine • Piscataway, NJAllergy & Immunology, Rheumatology
Allergy, Immunology and Rheumatology Physician
Dr. Afinogenova is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1100 Centennial Ave
Suite 202
Piscataway, NJ 08854Phone+1 732-562-1717- Is this information wrong?
Summary
- Dr. Yuliya Afinogenova is an Allergy, Immunology, and Rheumatology physician and is affiliated with Hackensack Medical Center. She received her medical degree from Harvard Medical School, completed Internal Medicine residency at Yale, followed by a unique dual fellowship in Allergy, Immunology and Rheumatology at Yale. She sees patients in both Allergy & Immunology as well as Rheumatology with office locations in North Arlington, Belleville, and Piscataway.
Education & Training
Yale-New Haven Medical CenterFellowship, Allergy and Immunology, 2018 - 2022- Yale-New Haven Medical CenterFellowship, Rheumatology, 2018 - 2022
Harvard Medical SchoolClass of 2015
Certifications & Licensure
NJ State Medical License 2022 - 2025
CT State Medical License 2017 - 2022- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 7 citationsDefining Clinical and Immunological Predictors of Poor Immune Responses to COVID-19 mRNA Vaccines in Patients with Primary Antibody Deficiency.Junghee Jenny Shin, Jennefer Par-Young, Serhan Unlu, Andrew McNamara, Hong-Jai Park, Min Sun Shin, Renelle J Gee, Hester Doyle, Yuliya Afinogenova, Elena Zidan, Jason ...> ;Journal of Clinical Immunology. 2022 Aug 1
- 14 citationsUpdate on gout management: what is old and what is new.Yuliya Afinogenova, Abhijeet Danve, Tuhina Neogi> ;Current Opinion in Rheumatology. 2022 Mar 1
- Concurrent use of tumor necrosis factor inhibitor and tyrosine kinase inhibitor in ankylosing spondylitis and myeloid neoplasm.Akash Gupta, Yuliya Afinogenova, Nikolai A Podoltsev, Abhijeet Danve> ;European Journal of Rheumatology. 2022 Oct 1
- Join now to see all
Press Mentions
Aching Back? Could It Be Axial Spondyloarthritis?May 18th, 2021
Hospital Affiliations
Hackensack Meridian Health Hackensack University Medical CenterHackensack, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
